Related references
Note: Only part of the references are listed.Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function
Masih Khedri et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study
Moman A. Mohammad et al.
EUROINTERVENTION (2017)
Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91 360 patients admitted with index myocardial infarction between 1998 and 2010
Liyew Desta et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure
Catherine Girouard et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
Etienne Puymirat et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
Etienne Puymirat et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes
Baris Gencer et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Incidence, Temporal Trends, and Prognostic Impact of Heart Failure Complicating Acute Myocardial Infarction The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): A Study of 199,851 Patients Admitted With Index Acute Myocardial Infarctions, 1996 to 2008
Liyew Desta et al.
JACC-HEART FAILURE (2015)
Beta-blocker Use in ST-segment Elevation Myocardial Infarction in the Reperfusion Era (GRACE)
Kay Lee Park et al.
AMERICAN JOURNAL OF MEDICINE (2014)
β-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction Post Hoc Analysis From the CHARISMA Trial
Sripal Bangalore et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Beyond Medication Prescription as Performance Measures
Suzanne V. Arnold et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
Sripal Bangalore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing
Jeffrey J. Goldberger et al.
AMERICAN HEART JOURNAL (2010)
The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
Tomas Jernberg et al.
HEART (2010)
Medication Adherence Its Importance in Cardiovascular Outcomes
P. Michael Ho et al.
CIRCULATION (2009)
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
Cynthia A. Jackevicius et al.
CIRCULATION (2008)
ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
Harlan M. Krumholz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Jeppe N. Rasmussen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
A meta-analysis of the association between adherence to drug therapy and mortality
Scot H. Simpson et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction -: A report of the American College of Cardiology/American Heart Association Task Force on performance measures (Writing Committee to develop performance measures on ST-elevation and non-ST-elevation myocardial infarction)
HM Krumholz et al.
CIRCULATION (2006)
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease
LK Newby et al.
CIRCULATION (2006)
The validity of a diagnosis of heart failure in a hospital discharge register
E Ingelsson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Impact of medication adherence on hospitalization risk and healthcare cost
MC Sokol et al.
MEDICAL CARE (2005)
Discharge education improves clinical outcomes in patients with chronic heart failure
TM Koelling et al.
CIRCULATION (2005)
Determinants and prognostic impact of heart failure complicating acute coronary syndromes observations from The Global Registry of Acute Coronary Events (GRACE)
PG Steg et al.
CIRCULATION (2004)
The value of inpatient pharmaceutical counselling to elderly patients prior to discharge
SA Al-Rashed et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Effect of carvedilol on survival in severe chronic heart failure.
M Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
